This PeerView inQuiry activity, which will present the most current knowledge regarding the pathogenesis of GKDs, the latest evidence on new and emerging therapies for their treatment, and practical guidance on the integration of these agents into clinical practice as they become available. This 0.5-hour CME-certified activity is designed to meet the educational demands of busy clinicians while delivering an effective, personalized learning experience. Through brief, mobile-friendly Q&A segments with discussion and reassessment, inQuiry activities promote more efficient initial knowledge acquisition, retention, and application of concepts. inQuiry uses a self-assessment format combined with problem-based learning that increases confidence and empowers people to act.
- Provider:University of Cincinnati College of Medicine
- Activity Link: https://uc.cloud-cme.com/course/courseoverview?EID=34114
- Start Date: 2024-06-05 05:00:00
- End Date: 2024-06-05 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Novartis Pharmaceuticals - Amount: 154205.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all